Development Level

Tbio 4 | 10,625
Tchem 2 | 1,890

IMPC Term

preweaning lethality, complete... 2 | 633
decreased bone mineral density 1 | 126
decreased grip strength 1 | 123
small heart 1 | 8
small kidney 1 | 10
small liver 1 | 8
small lung 1 | 5
small spleen 1 | 11

Disease

Cancer 4 | 2,346
lung cancer 4 | 4,466
ovarian cancer 4 | 8,484
adult high grade glioma 2 | 2,148
astrocytic glioma 2 | 2,241
dermatomyositis 2 | 933
intraductal papillary-mucinous neoplasm (IPMN) 2 | 3,289
malignant mesothelioma 2 | 3,162
medulloblastoma, large-cell 2 | 6,234
osteosarcoma 2 | 7,933
psoriasis 2 | 6,685
sonic hedgehog group medulloblastoma 2 | 1,482
spina bifida 2 | 1,064
Allergic hypersensitivity disease 1 | 123
Amphetamine-Related Disorders 1 | 74
Anemia 1 | 252
Atopic dermatitis 1 | 944
Barrett's esophagus 1 | 183
Breast cancer 1 | 3,094
Chronic obstructive pulmonary disease 1 | 146
Cocaine-Related Disorders 1 | 88
Colorectal Neoplasms 1 | 217
Common variable immunodeficiency 1 | 72
Cromer blood group system 1 | 1
Disease Progression 1 | 125
Down syndrome 1 | 548
Endometriosis 1 | 535
FG syndrome 1 | 17
Gingival recession 1 | 14
Hepatitis B, Chronic 1 | 15
Hyperplasia 1 | 26
IGA Glomerulonephritis 1 | 454
Idiopathic Membranous Glomerulonephritis 1 | 18
Infertility 1 | 163
Kleefstra syndrome 1 | 9
Lung Neoplasms 1 | 171
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 2 1 | 3
Multiple myeloma 1 | 1,327
Neoplasm Invasiveness 1 | 127
Neoplasm Metastasis 1 | 138
Polycystic Ovary Syndrome 1 | 332
Proteinuria 1 | 63
Small cell carcinoma of lung 1 | 45
Stuttering 1 | 18
Waldenstrons macroglobulinemia 1 | 765
acute quadriplegic myopathy 1 | 1,157
adrenocortical carcinoma 1 | 1,427
ependymoma 1 | 2,514
esophageal adenocarcinoma 1 | 737
gastric carcinoma 1 | 832
group 3 medulloblastoma 1 | 2,254
group 4 medulloblastoma 1 | 1,875
interstitial cystitis 1 | 2,299
interstitial lung disease 1 | 291
intraductal papillary-mucinous adenoma (IPMA) 1 | 2,956
intraductal papillary-mucinous carcinoma (IPMC) 1 | 2,988
lung adenocarcinoma 1 | 2,713
lung carcinoma 1 | 2,844
nasopharyngeal carcinoma 1 | 1,056
non-small cell lung cancer 1 | 2,798
non-small cell lung carcinoma 1 | 413
oligodendroglioma 1 | 2,849
pancreatic cancer 1 | 2,300
pediatric high grade glioma 1 | 2,712
primary pancreatic ductal adenocarcinoma 1 | 1,271
tuberculosis and treatment for 6 months 1 | 686
ulcerative colitis 1 | 2,087

Tissue

Blood and immune system 6 | 17,995
Cardiovascular System 6 | 17,958
Digestive Tract 6 | 18,473
Endocrine System 6 | 18,512
Female tissues 6 | 18,647
Liver and Pancreas 6 | 18,136
Male tissues 6 | 17,969
Nervous System 6 | 18,561
Respiratory system 6 | 17,484
Skin and soft tissues 6 | 18,115
Urinary Tract 6 | 18,444

Target Family

Epigenetic 3 | 242
Non-IDG 2 | 11,971
Transcription Factor 1 | 1,400

Grant Application

5R01GM071004-06 6 | 6
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
REST corepressor 1 RCOR1 Tbio Transcription Factor -1.90299 74.3 0
Complement decay-accelerating factor CD55 Tbio Non-IDG -3.01447 1054.4 786
Lysine-specific histone demethylase 1A KDM1A Tchem Epigenetic -2.57701 431.9 435
Chromodomain Y-like protein CDYL Tbio Epigenetic -1.07177 14.0 151
C-terminal-binding protein 1 CTBP1 Tbio Non-IDG -2.42162 269.3 377
Histone-lysine N-methyltransferase EHMT2 EHMT2 Tchem Epigenetic -2.40965 285.5 240